Ibudilast, labelled MN-166 by MediciNova, is a potential oral treatment for all forms of multiple sclerosis (MS) and for other neurodegenerative disorders, like amyotrophic lateral sclerosis.
Also reported to be used to treat ocular allergic symptoms, itching and dry eye sensations.
API's & Drug Standards
Send us your enquiry for Ibudilast. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Ibudilast email us and we will include your contribution on the website.